litlas
Log inCreate account

John M. Davis

Active 1965–2026

Also published as
John M Davis · JOHN M. DAVIS
358
Papers
65,791
Citations
132
h-index
341
i10-index

Citations

Citations per year for John M. Davis1962: 1 citations1968: 3 citations1969: 6 citations1970: 8 citations1971: 10 citations1972: 16 citations1973: 12 citations1974: 17 citations1975: 15 citations1976: 32 citations1977: 21 citations1978: 29 citations1979: 32 citations1980: 42 citations1981: 49 citations1982: 33 citations1983: 36 citations1984: 34 citations1985: 42 citations1986: 38 citations1987: 55 citations1988: 42 citations1989: 32 citations1990: 36 citations1991: 31 citations1992: 33 citations1993: 47 citations1994: 29 citations1995: 48 citations1996: 41 citations1997: 69 citations1998: 75 citations1999: 77 citations2000: 101 citations2001: 110 citations2002: 120 citations2003: 150 citations2004: 156 citations2005: 205 citations2006: 256 citations2007: 359 citations2008: 436 citations2009: 427 citations2010: 523 citations2011: 489 citations2012: 545 citations2013: 491 citations2014: 568 citations2015: 537 citations2016: 483 citations2017: 487 citations2018: 435 citations2019: 1,385 citations2020: 1,539 citations2021: 1,553 citations2022: 1,317 citations2023: 983 citations2024: 1,695 citations2025: 822 citations2026: 38 citations1963–1967: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,865 citing papers, 24.7% of this breakdownChina: 1,948 citing papers, 8.2% of this breakdownUnited Kingdom: 1,931 citing papers, 8.1% of this breakdownGermany: 1,402 citing papers, 5.9% of this breakdownCanada: 1,166 citing papers, 4.9% of this breakdownItaly: 957 citing papers, 4% of this breakdownAustralia: 840 citing papers, 3.5% of this breakdownFrance: 658 citing papers, 2.8% of this breakdownSpain: 641 citing papers, 2.7% of this breakdownJapan: 603 citing papers, 2.5% of this breakdownNetherlands: 586 citing papers, 2.5% of this breakdownSweden: 492 citing papers, 2.1% of this breakdown
0%24.7%Other 28.1%

Institutions

Fields

  • Medicine44.9%
  • Biochemistry, Genetics and Molecular Biology20%
  • Neuroscience10.5%
  • Agricultural and Biological Sciences6.3%
  • Psychology5.3%
  • Nursing3.1%
  • Other9.9%

Topics

  • Schizophrenia research and treatment6.6%
  • Bipolar Disorder and Treatment2.3%
  • Tryptophan and brain disorders2.3%
  • Rheumatoid Arthritis Research and Therapies2.1%
  • Treatment of Major Depression1.8%
  • Gut microbiota and health1.5%
  • Other83.4%

Coauthors

All papers

Open in search
  1. Comparative Efficacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults With Multi-Episode Schizophrenia: A Systematic Review and Network Meta-Analysis

    Authors: Maximilian Huhn, Adriani Nikolakopoulou, Johannes Schneider‐Thoma, Marc Krause, Myrto Samara, Natalie Peter, Thomas J. Arndt, Lio Bäckers, Philipp Rothe, Andrea Cipriani, John M. Davis, Georgia Salanti, Stefan Leucht - FOCUS The Journal of Lifelong Learning in Psychiatry 2019 cited by 1,744

  2. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis

    Authors: Jun Chen, Kerry Wright, John M. Davis, Patricio Jeraldo, Eric Marietta, Joseph A. Murray, Heidi Nelson, Eric L. Matteson, Veena Taneja - Genome Medicine 2016 cited by 851

  3. The Genome of Black Cottonwood, Populus trichocarpa (Torr. & Gray)

    Authors: Gerald A. Tuskan, Stephen DiFazio, Stefan Jansson, Jöerg Bohlmann, Igor V. Grigoriev, Uffe Hellsten, Nicholas H. Putnam, Steven Ralph, Stéphane Rombauts, Asaf Salamov, Jacqueline E. Schein, Lieven Sterck, Andrea Aerts, R. R. Bhalerao, Rishikesh P. Bhalerao, Damien Blaudez, Wout Boerjan, Annick Brun, Amy M. Brunner, Victor Busov, Malcolm M. Campbell, John E. Carlson, Michel Chalot, Jarrod Chapman, G.-L. Chen, Dawn Cooper, Pedro M. Coutinho, Jérémy Couturier, Sarah F. Covert, Quentin Cronk, Richard P. Cunningham, John M. Davis, Sven Degroeve, Annabelle Déjardin, Claude W. dePamphilis, John C. Detter, Bill Dirks, Inna Dubchak, Sébastien Duplessis, Jürgen Ehlting, B. E. Ellis, Karla Gendler, David Goodstein, Michael Gribskov, Jane Grimwood, Andrew Groover, Lee E. Gunter, Björn Hamberger, Berthold Heinze, Ykä Helariutta, Bernard Henrissat, D. Holligan, Robert A. Holt, Wenjiang Huang, Nurul Islam‐Faridi, Steven J.M. Jones, Matthew W. Jones-Rhoades, Richard A. Jorgensen, Chandrashekhar P. Joshi, Jaakko Kangasjärvi, Jan Karlsson, Colin T. Kelleher, Robert B. Kirkpatrick, Matias Kirst, Annegret Kohler, Udaya C. Kalluri, Frank W. Larimer, Jim Leebens‐Mack, Jean‐Charles Leplé, Philip LoCascio, Yonggen Lou, Susan Lucas, Francis Martin, Barbara Montanini, Carolyn A. Napoli, David R. Nelson, C. Dana Nelson, Kaisa Nieminen, Ove Nilsson, V. Pereda, G. F. Peter, Ryan N. Philippe, Gilles Pilate, Alexandre Poliakov, Jane Razumovskaya, Paul Richardson, Cécile Rinaldi, Kermit Ritland, Pierre Rouzé, Dmitriy Ryaboy, Jeremy Schmutz, Jarmo Schrader, Bo Segerman, H. Shin, Asim Siddiqui, Fredrik Sterky, Astrid Terry, Chung‐Jui Tsai, Ed Uberbacher, Per Unneberg and 10 more - Science 2006 cited by 4,473

  4. A predictive index for health status using species-level gut microbiome profiling

    Authors: Vinod K. Gupta, Minsuk Kim, Utpal Bakshi, Kevin Y. Cunningham, John M. Davis, Konstantinos N. Lazaridis, Heidi Nelson, Nicholas Chia, Jaeyun Sung - Nature Communications 2020 cited by 331

  5. Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.

    Authors: Stefan Leucht, Myrto Samara, Stephan Heres, John M. Davis - Schizophrenia Bulletin 2016 cited by 744

  6. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

    Authors: Stefan Leucht, Andrea Cipriani, Loukia M. Spineli, Dimitris Mavridis, Deniz Örey, Franziska Richter, Myrto Samara, Corrado Barbui, Rolf R. Engel, John Geddes, Werner Kissling, Marko Paul Stapf, Bettina Lässig, Georgia Salanti, John M. Davis - The Lancet 2013 cited by 2,537

  7. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

    Authors: Joshua J. Solomon, Sonye K. Danoff, Felix Woodhead, Shelley Hurwitz, Rie Maurer, Ian Glaspole, Paul F. Dellaripa, Bibek Gooptu, Robert Vassallo, Gerard Cox, Kevin R. Flaherty, Huzaifa Adamali, Michael Gibbons, Lauren Troy, Ian Forrest, Joseph A. Lasky, Lisa Spencer, Jeffrey A. Golden, Mary Beth Scholand, Nazia Chaudhuri, Mark A. Perrella, David A. Lynch, Daniel C. Chambers, Martin Kolb, Cathie Spino, Ganesh Raghu, Hilary J. Goldberg, Iván O. Rosas, Shana Haynes-Harp, F. Poli, Coimbatore Sree Vidya, Rebecca R. Baron, Timothy Clouser, Tracy J. Doyle, Anthony H. Maeda, Kristin B. Highland, Jemima F. Albayda, Sarah E. Collins, Karthik Suresh, John M. Davis, Andrew H. Limper, Isabel Amigues, Kristina Eliopoulos, Jeffery J. Swigris, Stephen M. Humphries, John Huntwork, Chris Glynn, Steve Duncan, Maria I. Danila, Marilyn K. Glassberg, Elana M. Oberstein, Elizabeth A. Belloli, Linda Briggs, Vivek Nagaraja, Linda Cholewa, Donna DiFranco, Edward Green, Christie Liffick, Tanvi Naik, Genevieve Montas, Dorota Lebiedz‐Odrobina, Reba Bissell, Mark H. Wener, Lisa Lancaster, Leslie J. Crawford, Karmela K Chan, Robert J. Kaner, Alicia Morris, Xiaoping Wu, Nader Khalidi, Christopher J. Ryerson, Alyson W. Wong, Charlene D. Fell, Sharon LeClercq, Mark Hyman, Shane Shapera, Shikha Mittoo, Shireen Shaffu, Karl Gaffney, Andrew M. Wilson, Shaney Barratt, Harsha Gunawardena, Rachel K. Hoyles, Joel David, Namrata Kewalramani, Toby M. Maher, Philip L. Molyneaux, Maria Kokosi, Matthew Cates, Mandizha Mandizha, Abdul Ashish, Gladstone Chelliah, Helen Parfrey, Muhunthan Thillai, Josephine Vila, Sophie Fletcher, Paul Beirne, C Favager, Jo Brown, Julie Dawson and 7 more - The Lancet Respiratory Medicine 2022 cited by 208

  8. Is Oxytocin “Nature’s Medicine”?

    Authors: C. Sue Carter, William M. Kenkel, Evan L. MacLean, Steven Ray Wilson, Allison M. Perkeybile, Jason R. Yee, Craig F. Ferris, Hossein Pournajafi‐Nazarloo, Stephen W. Porges, John M. Davis, Jessica J. Connelly, Marcy A. Kingsbury - Pharmacological Reviews 2020 cited by 388

  9. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis

    Authors: Johannes Schneider-Thoma, Konstantina Chalkou, Carola Dörries, Irene Bighelli, Anna Ceraso, Maximilian Huhn, Spyridon Siafis, John M Davis, Andrea Cipriani, Toshi A Furukawa, Georgia Salanti, Stefan Leucht - The Lancet 2022 cited by 216

  10. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985–2014

    Authors: Elena Myasoedova, John M. Davis, Eric L. Matteson, Cynthia S. Crowson - Annals of the Rheumatic Diseases 2020 cited by 255

  11. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors

    Authors: Stefan Leucht, Claudia Leucht, Maximilian Huhn, Anna Chaimani, Dimitris Mavridis, Bartosz Helfer, Myrto Samara, Matteo Rabaioli, Susanne Bächer, Andrea Cipriani, John Geddes, Georgia Salanti, John M. Davis - American Journal of Psychiatry 2017 cited by 536

  12. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

    Authors: Stefan Leucht, Caroline Corves, Dieter Arbter, Rolf R. Engel, Chunbo Li, John M. Davis - The Lancet 2008 cited by 1,916

  13. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia

    Authors: Stefan Leucht, Alessio Crippa, Spyridon Siafis, Maxine X. Patel, Nicola Orsini, John M. Davis - American Journal of Psychiatry 2019 cited by 294

  14. Guidelines for the use of cell lines in biomedical research

    Authors: R J Geraghty, Amanda Capes‐Davis, John M. Davis, Julian Downward, R. Ian Freshney, Ivana Knežević, Robin Lovell‐Badge, John R. Masters, J Meredith, G N Stacey, P Thraves, Maria Vias - British Journal of Cancer 2014 cited by 513

  15. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

    Authors: Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling, Georgia Salanti, John M. Davis - The Lancet 2012 cited by 923

  16. Why women have more autoimmune diseases than men: An evolutionary perspective

    Authors: Vanessa L. Kronzer, S. Louis Bridges, John M. Davis - Evolutionary Applications 2020 cited by 139

  17. Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method

    Authors: Stefan Leucht, Myrto Samara, Stephan Heres, Maxine X. Patel, Scott W. Woods, John M. Davis - Schizophrenia Bulletin 2014 cited by 374

  18. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases

    Authors: Cynthia S. Crowson, Eric L. Matteson, Elena Myasoedova, Clement J. Michet, Floranne C. Ernste, Kenneth J. Warrington, John M. Davis, Gene G. Hunder, Terry M. Therneau, Sherine E. Gabriel - Arthritis & Rheumatism 2010 cited by 647

  19. Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis

    Authors: Spyridon Siafis, Hui Wu, Dongfang Wang, Angelika Burschinski, Nobuyuki Nomura, Hiroyoshi Takeuchi, Johannes Schneider‐Thoma, John M. Davis, Stefan Leucht - Molecular Psychiatry 2023 cited by 130

  20. Metabolic side effects in persons with schizophrenia during mid‐ to long‐term treatment with antipsychotics: a network meta‐analysis of randomized controlled trials

    Authors: Angelika Burschinski, Johannes Schneider‐Thoma, Virginia Chiocchia, Kristina Schestag, Dongfang Wang, Spyridon Siafis, Irene Bighelli, Hui Wu, Wulf‐Peter Hansen, Josef Priller, John M. Davis, Georgia Salanti, Stefan Leucht - World Psychiatry 2023 cited by 96

  21. Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method

    Authors: Stefan Leucht, Myrto Samara, Stephan Heres, Maxine X. Patel, Toshi A. Furukawa, Andrea Cipriani, John Geddes, John M. Davis - Schizophrenia Bulletin 2015 cited by 313

  22. The Altman Self-Rating Mania Scale

    Authors: Edward G. Altman, Donald Hedeker, James L. Peterson, John M. Davis - Biological Psychiatry 1997 cited by 858

  23. Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials

    Authors: Hui Wu, Spyridon Siafis, Tasnim Hamza, Johannes Schneider‐Thoma, John M. Davis, Georgia Salanti, Stefan Leucht - Schizophrenia Bulletin 2022 cited by 121

  24. Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease

    Authors: Vanessa L. Kronzer, Weixing Huang, Paul F. Dellaripa, Sicong Huang, Vivi Feathers, Bing Lü, Christine Iannaccone, Ritu R. Gill, Hiroto Hatabu, Mizuki Nishino, Cynthia S. Crowson, John M. Davis, Michael E. Weinblatt, Nancy A. Shadick, Tracy J. Doyle, Jeffrey A. Sparks - The Journal of Rheumatology 2020 cited by 109